Cerebras Systems Inc. (CBRS) is a Sunnyvale, California-based AI infrastructure company that designs wafer-scale processors and rack-scale systems for training and, increasingly, high-speed inference in data centers. The stock traded at $96.81 on Wednesday morning, a decline of 7.07% from Tuesday's close of $104.18, confirming a clear downward move for the session. The retreat came without a company announcement, filing, or fresh analyst revision. Instead, markets appear to be unwinding part of a sharp two-week rebound in a stock that has become highly sensitive to the broader debate over AI valuations.
No verified news or fundamental catalyst found during this session points to Cerebras specifically. The company's most recent material disclosure — third-quarter results and forward guidance — was released on November 12, and the wave of related analyst price-target cuts from Morgan Stanley, Wedbush, and UBS has already been absorbed. Wednesday's action is therefore best assessed as position-squaring rather than a reaction to new information. Shares had rallied from an intraday low of $77.84 on November 5 to $104.18 by Tuesday's close, a gain of about 27%, and the pullback is consistent with profit-taking after that run. It is also consistent with the stock's habit of large swings: over the past several months it has frequently moved by 7% or more in a single session, reflecting an investor base that trades the name aggressively around AI sentiment.
The broader driver is sentiment toward high-multiple AI infrastructure names. Attention has returned to the performance of 2026's largest technology listings, several of which now trade below their first-day prices, and to questions about valuation discipline as another highly anticipated AI offering is scrutinized. Cerebras, which priced its May IPO at $185 and peaked near $386 on its debut, sits at the center of that debate. Traders are also trimming exposure ahead of Nvidia's quarterly report, a bellwether event that typically sets the tone for accelerators, inference capacity, and AI capital spending. Persistent overhangs — including the short-seller allegations published earlier this autumn, related law-firm investigations, and heavy customer concentration, with two clients accounting for 72% of third-quarter revenue — keep the rebound fragile.
Trading has been unusually heavy in Cerebras over the past two weeks: volume exceeded 21 million shares on November 13, roughly double the 20-day average near 12.7 million, and remained elevated through the post-earnings stretch, in line with the pattern of a heavily traded, high-beta name. The stock's market capitalization stands near $23.5 billion, with short interest equal to roughly 9% of shares outstanding and about 14.5% of the float. Technically, the shares are trading well beneath the 50-day moving average of about $146.93, with support around the November 5 low of $77.84 and resistance in the $104-$108 area established by the recent rebound. The move broadly reflects weakness across AI hardware and semiconductor equities rather than company-specific selling pressure.
The scale runs from 0 — no meaningful news and a routine move — to 100, which would require transformative verified news paired with an extreme, rare price swing. Cerebras earns 12 out of 100. Verified news strength was minimal: the session featured no disclosure, no fresh rating change, and only general sector-level commentary, which carries little weight against a company of this size. The price move was also unremarkable by the stock's own standards. Wednesday's decline was roughly 1.3 times the typical absolute daily move of about 5.3%, and moves of 7% or more have occurred 14 times in the last 60 sessions. Weak news plus an ordinary swing for this name produces a low score.
Investors will focus on the fourth quarter, for which management has guided core revenue of $310 million to $330 million and core operating margins between negative 1% and positive 1%, alongside a full-year core revenue target of $940 million to $960 million and a reiterated goal of tripling revenue in 2027. Results are expected in February. Execution on the OpenAI capacity build-out, which management expects to return to schedule in the second half of 2027, and the ramp of new hyperscaler relationships with Microsoft (MSFT), Amazon (AMZN), and Oracle (ORCL) are the key swing factors. Risks include customer concentration, gross-margin pressure from rented capacity, further lock-up-related supply, and the possibility that AI infrastructure spending expectations reset lower.
Tickeron's Trending AI Robots page highlights the automated strategies performing best under current market conditions. Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, but this curated section surfaces only the strongest performers, so the list changes as conditions shift. Bots differ by strategy logic, holding timeframe, performance metrics, and the symbols they trade, allowing users to compare approaches side by side. For traders navigating a volatile name like Cerebras, it is a practical starting point for research — explore the page to see which robots currently lead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 5 cases where CBRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 16, 2026. You may want to consider a long position or call options on CBRS as a result. In 10 of 11 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for CBRS just turned positive on November 09, 2026. Looking at past instances where CBRS's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.
Following a +18.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRS advanced for three days, in 17 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.327) is normal, around the industry mean (5.443). P/E Ratio (-19.264) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors